Topical compositions

Patent metadata

Field	Value
Publication number	US-10500220-B2
Application number	US-201816209542-A
Country	US
Kind code	B2
Filing date	Dec 4, 2018
Priority date	Jul 5, 2011
Publication date	Dec 10, 2019
Grant date	Dec 10, 2019

Abstract

Provided herein are anhydrous compositions that include at least one viscosity increasing agent, at least one organic solvent and at least one humectant. Such compositions may also include at least one active pharmaceutical ingredient (API) and/or at least one water repellant. Related compositions, methods and kits are also provided.

First claim

That which is claimed is:

1. A method of decreasing abnormal keratinization, reducing microbial colonization, reducing inflammation and/or decreasing sebum production in a subject in need thereof, the method comprising applying an anhydrous composition to the skin of a subject to treat the dermatological condition,
wherein the anhydrous composition consists essentially of:
hydroxypropyl cellulose at a concentration in a range of 0.5% to about 2% by weight of the anhydrous composition,
ethanol or isopropyl alcohol at a concentration in a range of 45% to 90% by weight of the anhydrous composition,
hexylene glycol at a concentration of about 10% by weight of the anhydrous composition,
cyclomethicone at a concentration of about 2.5% by weight of the anhydrous composition, and
a nitric oxide (NO)-releasing compound at a concentration in a range of 0.01% to 40% by weight of the anhydrous composition,
wherein the method decreases abnormal keratinization, microbial colonization, inflammation, and/or sebum production in the skin of the subject.

2. The method of claim 1 , wherein the subject has acne and the method comprises treating the acne.

3. The method of claim 1 , wherein the anhydrous composition comprises ethanol.

4. The method of claim 1 , wherein the anhydrous composition comprises isopropyl alcohol.

5. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration in a range of 0.01% to 30% by weight of the anhydrous composition.

6. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration in a range of 0.01% to 2% by weight of the anhydrous composition.

7. The method of claim 1 , wherein the hydroxypropyl cellulose is present in the anhydrous composition at a concentration in a range of 0.5% to about 1% by weight of the anhydrous composition.

8. The method of claim 1 , wherein the hydroxypropyl cellulose is present in the anhydrous composition at a concentration of about 1% by weight of the anhydrous composition.

9. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 1% by weight of the anhydrous composition.

10. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 2% by weight of the anhydrous composition.

11. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 4% by weight of the anhydrous composition.

12. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 8% by weight of the anhydrous composition.

13. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 12% by weight of the anhydrous composition.

14. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 16% by weight of the anhydrous composition.

15. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 20% by weight of the anhydrous composition.

16. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 24% by weight of the anhydrous composition.

17. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 30% by weight of the anhydrous composition.

18. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 32% by weight of the anhydrous composition.

19. The method of claim 1 , wherein the NO-releasing compound comprises diazeniumdiolated co-condensed silica particles.

20. The method of claim 1 , wherein the method decreases abnormal keratinization in the skin of the subject.

21. The method of claim 1 , wherein the method decreases microbial colonization in the skin of the subject.

22. The method of claim 1 , wherein the method decreases inflammation in the skin of the subject.

23. The method of claim 1 , wherein the method decreases sebum production in the skin of the subject.

24. A method of treating a dermatological condition, the method comprising applying an anhydrous composition to the skin of a subject to treat the dermatological condition,
wherein the anhydrous composition consists essentially of:
hydroxypropyl cellulose at a concentration in a range of 0.5% to about 2% by weight of the anhydrous composition,
ethanol or isopropyl alcohol at a concentration in a range of 45% to 90% by weight of the anhydrous composition,
hexylene glycol at a concentration of about 10% by weight of the anhydrous composition,
cyclomethicone at a concentration of about 2.5% by weight of the anhydrous composition, and
a nitric oxide (NO)-releasing compound at a concentration in a range of 0.01% to 40% by weight of the anhydrous composition,
wherein the dermatological condition comprises acne, a scar, a wound, and/or a biofilm.

25. The method of claim 24 , wherein the dermatological condition comprises acne.

26. The method of claim 24 , wherein the dermatological condition comprises a scar.

27. The method of claim 24 , wherein the dermatological condition comprises a wound.

28. The method of claim 24 , wherein the dermatological condition comprises a biofilm.

Assignees

• Novan Inc

Inventors

• Doxey Ryan
• Stasko Nathan

Classifications

• A61P17/10

  Anti-acne agents · CPC title

• A61P17/02

  for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title

• A61P17/00

  Drugs for dermatological disorders · CPC title

• A61K2800/22

  Gas releasing · CPC title

• A61K8/891

  saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone · CPC title